Iterum Therapeutics plcIterum Therapeutics plcIterum Therapeutics plc

Iterum Therapeutics plc

No trades
See on Supercharts

Price target

7.000.000.00%
The 2 analysts offering 1 year price forecasts for ITRM have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to ITRM in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ITRM EPS for the last quarter is −0.12 USD despite the estimation of −0.17 USD. In the next quarter EPS is expected to reach −0.14 USD. Track more of Iterum Therapeutics plc financials and stay on top of what is up with the company.
In the next quarter Iterum Therapeutics plc revenue is expected to reach 0.00 USD. Check out Iterum Therapeutics plc revenue and earnings and make informed decisions.
According to analysts, ITRM price target is 7.00 USD with a max estimate of 9.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Iterum Therapeutics plc stock price chart and keep track of the current situation with ITRM news and stock market news.